(Q24240283)

6

object named as

Shah Ebrahim

0 references

author name string

Fiona Taylor

1

0 references

Kirsten Ward

2

0 references

Theresa HM Moore

3

0 references

Margaret Burke

Cochrane Database of Systematic Reviews

4

0 references

publication date

21 January 2009

0 references

published in

0 references

cites work

Are lipid-lowering guidelines evidence-based?

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004816.PUB3

Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004816.PUB3

Women, older persons, and ethnic minorities: factors associated with their inclusion in randomised trials of statins 1990 to 2001.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004816.PUB3

The causes and effects of socio-demographic exclusions from clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004816.PUB3

Stroke, statins, and cholesterol. A meta-analysis of randomized, placebo-controlled, double-blind trials with HMG-CoA reductase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004816.PUB3

Effects of statins on stroke prevention in patients with and without coronary heart disease: a meta-analysis of randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004816.PUB3

Serum cholesterol concentration and coronary heart disease in population with low cholesterol concentrations

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004816.PUB3

Meta-analysis of large randomized controlled trials to evaluate the impact of statins on cardiovascular outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004816.PUB3

Statins and cancer risk: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004816.PUB3

Plasma cholesterol concentration and mortality. The Whitehall Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004816.PUB3

Identifying relevant studies for systematic reviews

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004816.PUB3

Cholesterol and coronary heart disease: screening and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004816.PUB3

Selected major risk factors and global and regional burden of disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004816.PUB3

Reducing the growing burden of cardiovascular disease in the developing world

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004816.PUB3

MRC/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes: a randomised placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004816.PUB3

Serum total cholesterol and risk of hospitalization, and death from respiratory disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004816.PUB3

Statins for primary prevention: at what coronary risk is safety assured?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004816.PUB3

Reduced cholesterol is associated with recent minor illness: the CARDIA Study. Coronary Artery Risk Development in Young Adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004816.PUB3

Risks associated with statin therapy: a systematic overview of randomized clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004816.PUB3

Variability in meta-analytic results concerning the value of cholesterol reduction in coronary heart disease: a meta-meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004816.PUB3

Quantifying effect of statins on low density lipoprotein cholesterol, ischaemic heart disease, and stroke: systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004816.PUB3

Effects of lovastatin on cognitive function and psychological well-being

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004816.PUB3

Cholesterol reduction and non-illness mortality: meta-analysis of randomised clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004816.PUB3

Use of lipid lowering drugs for primary prevention of coronary heart disease: meta-analysis of randomised trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004816.PUB3

Blood cholesterol and vascular mortality by age, sex, and blood pressure: a meta-analysis of individual data from 61 prospective studies with 55,000 vascular deaths

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004816.PUB3

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004816.PUB3

Primary prevention of cardiovascular diseases with statin therapy: a meta-analysis of randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004816.PUB3

Variations and increase in use of statins across Europe: data from administrative databases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004816.PUB3

A systematic review and economic evaluation of statins for the prevention of coronary events.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004816.PUB3

Randomised placebo controlled trial of effect on mood of lowering cholesterol concentration. Oxford Cholesterol Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004816.PUB3

Effectiveness of statin therapy in adults with coronary heart disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004816.PUB3

Global burden of cardiovascular diseases: part I: general considerations, the epidemiologic transition, risk factors, and impact of urbanization

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004816.PUB3

Investigating and Dealing with Publication and Other Biases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004816.PUB3

Effect of statins on risk of coronary disease: a meta-analysis of randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004816.PUB3

inferred from DOI database lookup

7 January 2021

based on heuristic

Targeting lipid-lowering drug therapy for primary prevention of coronary disease: an updated Sheffield table

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004816.PUB3

inferred from DOI database lookup

7 January 2021

based on heuristic

Use of statins in primary and secondary prevention of coronary heart disease and ischemic stroke. Meta-analysis of randomized trials.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004816.PUB3

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1002/14651858.CD004816.PUB3

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

2386542

OpenCitations bibliographic resource ID

2386542

1 reference